Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis
Cell Reports · 2026-10 · 45 (10) · 118003
DOI: 10.1016/j.celrep.2026.118003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Shoya Matsumoto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The …. Hauptthemen laut MEDLINE: Muscle, Skeletal, Homeostasis, Phosphatidylcholines, Lysophospholipase. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Government of Japan Ministry of Education Culture Sports Science and Technology, Japan Science and Technology Agency.
Abstract (Originalsprache)
Current evidence suggests that disturbed phosphatidylcholine (PC) turnover causes skeletal muscle dysfunction. However, the enzyme that converts lysophosphatidylcholine (LPC) to glycerophosphocholine (GPC), an irreversible checkpoint in PC catabolism, in skeletal muscle has remained unidentified. Here we show that PNPLA7, a patatin-like phospholipase isoform, is responsible for this process. Pnpla7 deletion in myoblasts impedes the conversion of LPC to GPC and then to choline. Quadriceps muscles in global Pnpla7-deficient mice display thinner muscle fibers with aberrant mitochondrial morphology, reduced endurance capacity, and decreased expression of genes related to fatty acid β-oxidation, mitochondrial functions, and slow-twitch fibers with age. These abnormalities are preceded by alterations in phospholipid composition, with decreases in docosahexaenoic acid-containing PC and mitochondrial cardiolipin. Moreover, skeletal muscle-specific Pnpla7 deficiency results in muscle phenotypes similar to its global deficiency. Identification of the lysophospholipase PNPLA7 aids further understanding of the role of PC turnover in skeletal muscle homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan; Department of Geriatric Me…
- Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
- Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan; Center for Basic Technolog…
- Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.
- Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
- Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan; Institute for Protein Research, Osaka University, O…
Förderung
- Japan Agency for Medical Research and Development
- Government of Japan Ministry of Education Culture Sports Science and Technology
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Matsumoto, S., Seo, H., Taketomi, Y., Higashi, T., Nagasaki, Y., Sato, H., Kawaguchi, M., Nishito, Y., Park, J., Mizuguchi, K., Hosomi, K., Kunisawa, J., Saito, K., Kato, K., Soga, T., Hirabayashi, T., Ogawa, S., & Murakami, M. (2026). Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis. Cell Reports, 45(10), 118003. https://doi.org/10.1016/j.celrep.2026.118003
Vancouver
Matsumoto S, Seo H, Taketomi Y, Higashi T, Nagasaki Y, Sato H, et al. Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis. Cell Reports. 2026;45(10):118003. doi:10.1016/j.celrep.2026.118003
BibTeX
@article{Matsumoto2026,
author = {Matsumoto, Shoya and Seo, Heeyoon and Taketomi, Yoshitaka and Higashi, Takayoshi and Nagasaki, Yuki and Sato, Hiroyasu and Kawaguchi, Mai and Nishito, Yasumasa and Park, Jonguk and Mizuguchi, Kenji and Hosomi, Koji and Kunisawa, Jun and Saito, Kaori and Kato, Keiko and Soga, Tomoyoshi and Hirabayashi, Tetsuya and Ogawa, Sumito and Murakami, Makoto},
title = {Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {10},
pages = {118003},
doi = {10.1016/j.celrep.2026.118003}
}
EUVIMED